Interaction of Glucagon G-Protein Coupled Receptor with Known Natural Antidiabetic Compounds: Multiscoring <i>In Silico</i> Approach

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Complexed/uncomplexed</td><td align="center">Change in ASA (Å<sup>2</sup>)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">4L6R (UC)</td><td align="center">18930.488</td></tr><tr><td align="left">4L6R (complexed with curcumin)</td><td align="center">18637.703</td></tr><tr><td align="left">4L6R (complexed with 4-hydroxyderricin)</td><td align="center">18661.982</td></tr><tr><td align="left">4L6R (complexed with amorfrutin 1)</td><td align="center">18674.038</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Total change in ASA of GCGR in uncomplexed and complexed form.

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Interaction of Glucagon G-Protein Coupled Receptor with Known Natural Antidiabetic Compounds: Multiscoring <i>In Silico</i> Approach 

Evidence-Based Complementary and Alternative Medicine

Interaction of Glucagon G-Protein Coupled Receptor with Known Natural Antidiabetic Compounds: Multiscoring In Silico Approach

Table 2